Axcynsis Therapeutics

Axcynsis Therapeutics is a biotechnology company focused on developing Antibody-X Conjugate (AXC) therapies for cancer treatment. The company utilizes proprietary technologies, including AxcynMAB™, AxcynCYS™, and AxcynDOT™, to build a pipeline of AXC candidates. These efforts aim to provide new treatment options addressing unmet medical needs in oncology.

Traction 8/10

Singapore · HQ

Founded 2022111K+ followers

Biotechnology

Updated 7 months ago

Funding

Raised to date

$21MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

1 founder

ZOU BIN

CEO

Product

Features

Axcynsis Therapeutics is a biotechnology company focused on developing Antibody-X Conjugate (AXC) therapies for cancer treatment. The company utilizes proprietary technologies, including AxcynMAB™, AxcynCYS™, and AxcynDOT™, to build a pipeline of AXC candidates. These efforts aim to provide new treatment options addressing unmet medical needs in oncology.